Compound Detail
CHEMBL412348
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
OCC1O[C@@H]2O[C@@H]3C(CO)O[C@H](O[C@@H]4C(CO)O[C@H](O[C@@H]5C(CO)O[C@@H](O[C@@H]6C(CO)O[C@H](O[C@@H]7C(C[Te]CC8O[C@@H]9O[C@@H]%10C(CO)O[C@@H](O[C@@H]%11C(CO)O[C@H](O[C@@H]%12C(CO)O[C@H](O[C@@H]%13C(CO)O[C@H](O[C@@H]%14C(CO)O[C@H](O[C@@H]%15C(CO)O[C@H](O[C@H]8C(O)C9O)C(O)C%15O)C(O)C%14O)C(O)C%13O)C(O)C%12O)C(O)C%11O)C(O)C%10O)O[C@H](O[C@@H]8C(CO)O[C@H](O[C@H]1C(O)C2O)C(O)C8O)C(O)C7O)C(O)C6O)C(O)C5O)C(O)C4O)C(O)C3O
Basic Information
| ChEMBL ID | CHEMBL412348 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HXQPYRLIMMRKRK-BLRXOPECSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
2363.6
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Thioredoxin reductase CHEMBL2096978 | IC50 | 6.3 | 5.96 | 500.0 | 2 |
| MCF7 CHEMBL387 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Thioredoxin reductase | IC50 | = | 500.0 | nM | 6.3 | Inhibition of thioredoxin reductase in the presence of thioredoxinand insulin | 14695837 |
| MCF7 | IC50 | = | 1400.0 | nM | 5.85 | Inhibition of growth of MCF-7 breast cancer cells in culture | 14695837 |
| Thioredoxin reductase | IC50 | = | 2400.0 | nM | 5.62 | Inhibition of thioredoxin reductase | 14695837 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 14695837 | 10.1021/jm030916r | Thioredoxin reductase | 2 |
| 14695837 | 10.1021/jm030916r | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine